Skip to main content

P 200 Pill - gray capsule/oblong

Pill with imprint P 200 is Gray, Capsule/Oblong and has been identified as Pazopanib Hydrochloride 200 mg. It is supplied by Novugen Pharma (USA) LLC.

Pazopanib is used in the treatment of Soft Tissue Sarcoma; Renal Cell Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Pazopanib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for P 200

Pazopanib Hydrochloride

Imprint
P 200
Strength
200 mg
Color
Gray
Shape
Capsule/Oblong (modified capsule-shaped, film-coated tablet)
Availability
Prescription only
Drug Class
VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novugen Pharma (USA) LLC
Manufacturer
Teyro Labs Private Limited
National Drug Code (NDC)
82293-0022

Get help with Imprint Code FAQs.

Related images for "P 200"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.